公众号 / 文章呼吸衰竭与机械通气

头盔无创支持治疗急性低氧性呼吸衰竭:原理、作用机制与床旁应用

Helmet noninvasive support for acute hypoxemic respiratory failure: rationale, mechanism of action and bedside application.
PubMed 文献 · Ann Intensive Care · 2022-10-14
一句话结论头盔无创支持可用于中重度低氧血症(PaO2/FiO2≤200 mmHg)非高碳酸血症患者的初始管理,但疗效尚无定论,需在受训人员与密切监测下使用。

本文为基于系统文献检索的叙述性综述,总结头盔无创支持治疗低氧性呼吸衰竭的原理、作用机制与技术细节。头盔可经颈部密封的罩式接口实施持续气道正压或压力支持通气,允许长时间应用10-15 cmH2O的较高呼气末正压且耐受性好,改善氧合并可能减轻肺与膈肌损伤。小型先导随机试验和网状Meta分析曾提出头盔支持可能降低插管风险的假设。作者认为头盔无创支持是重度低氧性呼吸衰竭初始管理有前景的工具,但目前缺乏使用经验与确切疗效数据,使用应限于特定场景并由受训人员实施,治疗中需密切临床与生理监测以早期识别失败、避免延误插管。

要点

  • 头盔接口在颈部密封、腋下系带固定,可经罩式接口无创实施持续气道正压或压力支持通气。
  • 对非高碳酸血症、中重度低氧血症(PaO2/FiO2≤200 mmHg)患者,头盔无创通气可能提供生理获益,部分因可长时间耐受10-15 cmH2O的呼气末正压。
  • 头盔支持可能改善氧合、限制通气不均一性,并可能减轻强烈吸气努力所致肺与膈肌损伤的潜在危害。
  • 头盔支持降低插管风险的潜在优势仅在小型先导随机试验和网状Meta分析中被提出假设。
  • 治疗中需密切临床与生理监测,早期识别治疗失败,避免延误插管。

适用人群与场景

  • 非高碳酸血症、中重度低氧血症(PaO2/FiO2≤200 mmHg)的急性低氧性呼吸衰竭患者。
  • 头盔无创支持适用于特定场景,需由有经验且受训的人员实施。

处置流程与药物剂量

  • 持续气道正压:经高流量发生器或Venturi系统连接至接口的吸气端口,并在头盔呼气端口放置呼气末正压阀。
  • 压力支持通气:通过双管回路将头盔连接至机械通气机实施。
  • 头盔接口可连续治疗并提供较高呼气末正压,患者舒适度良好。
  • 对非高碳酸血症、中重度低氧血症(PaO2/FiO2≤200 mmHg)患者,可长时间应用10-15 cmH2O的呼气末正压且耐受性良好。
  • 治疗期间需进行仔细的临床与生理监测,以早期识别治疗失败并避免延误插管。

红旗征与不能漏的情况

  • 治疗失败需早期识别,以避免延误插管。

研究设计与关键结果

  • 本文为基于系统文献检索的叙述性综述,总结头盔支持在低氧血症患者中的原理、作用机制与技术细节。
  • 初步数据显示,在非高碳酸血症、中重度低氧血症(PaO2/FiO2≤200 mmHg)患者中,头盔无创通气相较其他无创氧合策略(常规氧疗、面罩无创通气、经鼻高流量氧疗)可能提供生理获益。
  • 头盔支持降低插管风险的潜在优势仅在小型先导随机试验和网状Meta分析中被提出假设。

证据类型、等级与局限

  • 证据类型:基于系统文献检索的叙述性综述。
  • 目前缺乏使用经验与确切疗效数据,头盔使用限于特定场景并有受训人员参与。

对床旁实践的改变

  • 作者认为头盔无创支持是重度低氧性呼吸衰竭初始管理有前景的工具。
  • 目前头盔使用应限于特定场景,并由有经验且受训的人员实施。
  • 与其他无创氧合策略一样,治疗中需仔细临床与生理监测,以早期识别治疗失败并避免延误插管。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Helmet noninvasive support may provide advantages over other noninvasive oxygenation strategies in the management of acute hypoxemic respiratory failure. In this narrative review based on a systematic search of the literature, we summarize the rationale, mechanism of action and technicalities for helmet support in hypoxemic patients.

MAIN RESULTS: In hypoxemic patients, helmet can facilitate noninvasive application of continuous positive-airway pressure or pressure-support ventilation via a hood interface that seals at the neck and is secured by straps under the arms. Helmet use requires specific settings. Continuous positive-airway pressure is delivered through a high-flow generator or a Venturi system connected to the inspiratory port of the interface, and a positive end-expiratory pressure valve place at the expiratory port of the helmet; alternatively, pressure-support ventilation is delivered by connecting the helmet to a mechanical ventilator through a bi-tube circuit. The helmet interface allows continuous treatments with high positive end-expiratory pressure with good patient comfort. Preliminary data suggest that helmet noninvasive ventilation (NIV) may provide physiological benefits compared to other noninvasive oxygenation strategies (conventional oxygen, facemask NIV, high-flow nasal oxygen) in non-hypercapnic patients with moderate-to-severe hypoxemia (PaO2/FiO2 ≤ 200 mmHg), possibly because higher positive end-expiratory pressure (10-15 cmH2O) can be applied for prolonged periods with good tolerability. This improves oxygenation, limits ventilator inhomogeneities, and may attenuate the potential harm of lung and diaphragm injury caused by vigorous inspiratory effort. The potential superiority of helmet support for reducing the risk of intubation has been hypothesized in small, pilot randomized trials and in a network metanalysis.

CONCLUSIONS: Helmet noninvasive support represents a promising tool for the initial management of patients with severe hypoxemic respiratory failure. Currently, the lack of confidence with this and technique and the absence of conclusive data regarding its efficacy render helmet use limited to specific settings, with expert and trained personnel. As per other noninvasive oxygenation strategies, careful clinical and physiological monitoring during the treatment is essential to early identify treatment failure and avoid delays in intubation.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Cesarano M, Grieco DL, Michi T, et al. Helmet noninvasive support for acute hypoxemic respiratory failure: rationale, mechanism of action and bedside application. Ann Intensive Care. 2022. PMID: 36241926. doi:10.1186/s13613-022-01069-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。